Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
32.63
-0.27 (-0.82%)
At close: Feb 13, 2026

SHA:688139 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
10,14211,11212,82420,07828,79620,702
Market Cap Growth
0.03%-13.35%-36.13%-30.28%39.10%126.07%
Enterprise Value
9,0639,53010,93517,32725,93118,996
Last Close Price
32.6334.6739.3961.0486.9862.29
PE Ratio
40.2530.3131.5833.4234.0854.34
Forward PE
23.5917.5318.5325.8739.8050.27
PS Ratio
4.484.875.627.0113.5514.77
PB Ratio
2.212.412.894.847.917.44
P/TBV Ratio
3.163.463.986.179.429.25
P/FCF Ratio
72.3167.36177.9159.3774.3934.07
P/OCF Ratio
38.9638.1051.4531.7548.6629.72
EV/Sales Ratio
4.004.174.796.0512.2013.55
EV/EBITDA Ratio
30.3623.1726.6327.6552.8058.29
EV/EBIT Ratio
49.2431.0834.9430.6958.6762.69
EV/FCF Ratio
64.6257.77151.7051.2466.9931.26
Debt / Equity Ratio
0.000.010.000.010.000.01
Debt / EBITDA Ratio
0.060.060.040.040.010.08
Debt / FCF Ratio
0.120.140.250.080.020.04
Net Debt / Equity Ratio
-0.29-0.38-0.43-0.71-0.80-0.80
Net Debt / EBITDA Ratio
-4.52-4.27-4.63-4.71-5.90-6.85
Net Debt / FCF Ratio
-9.47-10.64-26.39-8.72-7.49-3.67
Asset Turnover
0.400.400.410.550.480.40
Inventory Turnover
4.234.094.534.843.583.93
Quick Ratio
1.962.092.272.682.692.36
Current Ratio
2.752.592.692.953.022.62
Return on Equity (ROE)
5.79%8.41%9.60%15.72%26.44%14.65%
Return on Assets (ROA)
2.04%3.39%3.55%6.79%6.25%5.42%
Return on Invested Capital (ROIC)
5.63%10.76%15.88%52.76%60.40%71.48%
Return on Capital Employed (ROCE)
3.90%6.40%6.80%13.10%11.80%10.50%
Earnings Yield
2.52%3.30%3.17%2.99%2.94%1.84%
FCF Yield
1.38%1.49%0.56%1.68%1.34%2.94%
Dividend Yield
1.44%1.36%1.31%0.74%0.57%0.61%
Payout Ratio
57.46%44.48%35.16%27.04%14.30%14.98%
Buyback Yield / Dilution
0.35%0.37%0.20%-0.06%2.43%-30.55%
Total Shareholder Return
1.77%1.73%1.51%0.68%3.01%-29.94%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.